Skip to page content
  • Glyko-engineered interleukin-4 based antagonists

    B77153

    Glyko-engineered interleukin-4 based antagonists

    • New strategy for the generation of a novel IL4-based IL4/IL13-Inhibitor
    • Innovative application of N-glycan structures for development of receptor antagonists
    • Applicable for following areas: atopic dermatitis, allergy and allergic asthma

2 of 90 Tech Offers

Interested? Get in touch!

Contact a specific team member for individual topics via the Team section or simply use our contact form. You can also click on the button and drop us a line.